We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

JOYY:NASDAQJOYY Inc. Analysis

Data as of 2026-05-20 - not real-time

$56.89

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

JOYY is trading at $56.89, which sits below its 20‑day SMA of 58.38, 50‑day SMA of 59.35, and 200‑day SMA of 60.46, indicating a bearish price bias. The stock is hovering just above its technical support of $56.08 and well under the resistance level of $60.62, suggesting limited upside in the immediate term. Momentum indicators reinforce this view: the 14‑day RSI is around 41.5, edging toward oversold territory, while the MACD line remains below its signal line, producing a bearish histogram. Volume trends are decreasing and 30‑day price volatility is high at roughly 30%, amplifying short‑term risk. Fundamentally, the company appears cheap – its trailing P/E of 13.5 is well below the industry average of 17.0, and the price‑to‑book ratio of 0.43 signals a deep discount to book value. The dividend yield is attractive at 7.45% with a payout ratio near 90%, but free cash flow is strongly negative, raising questions about the sustainability of the payout. Despite the technical weakness, the DCF‑derived fair value of $92.87 implies a potential upside of about 37%, and the low beta of 0.66 suggests limited market‑wide volatility exposure. The company’s modest revenue growth of 5.9% and thin operating margins temper growth expectations, positioning it more as a value play than a growth story.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price below key moving averages
  • Bearish MACD and decreasing volume
  • High short‑term volatility

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Significant DCF upside potential
  • Attractive dividend yield relative to peers
  • Low beta indicating defensive characteristics

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Undervalued valuation multiples vs industry
  • Potential for earnings improvement as free cash flow stabilizes
  • Diversified geographic footprint reducing single‑region exposure

Key Metrics & Analysis

Financial Health

Revenue Growth5.90%
Profit Margin98.72%
P/E Ratio13.5
ROE3.70%
ROA0.53%
Debt/Equity0.48
P/B Ratio0.4
Op. Cash Flow$302.3M
Free Cash Flow$-1422815488
Industry P/E17.1

Technical Analysis

TrendBearish
RSI41.5
Support$56.08
Resistance$60.62
MA 20$58.38
MA 50$59.35
MA 200$60.46
MACDBearish
VolumeDecreasing
Fear & Greed Index89.18

Valuation

Fair Value$92.87
Target Price$78.17
Upside/Downside37.41%
GradeUndervalued
TypeValue
Dividend Yield7.45%

Risk Assessment

Beta0.66
Volatility30.10%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.